BTLA Protein, Cynomolgus, Recombinant (His)

Ref. TM-TMPK-00530

Produktinformation

• Name: BTLA Protein, Cynomolgus, Recombinant (His)
• Synonyme: MGC129743, CD272, BTLA, BTLA1, FLJ16065

Beschreibung

B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. BTLA is a inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2. BTLA may interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14. BTLA Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 15.04 kDa and the accession number is A0A2K5W7M7.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 15.04 kDa (predicted). Due to glycosylation, the protein migrates to 35-40 kDa based on Tris-Bis PAGE result.
• Farbe/Form: Solid